IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge
10.1038/ni1449
Crossref journal-article
Springer Science and Business Media LLC
Nature Immunology (297)
Bibliography

Khader, S. A., Bell, G. K., Pearl, J. E., Fountain, J. J., Rangel-Moreno, J., Cilley, G. E., Shen, F., Eaton, S. M., Gaffen, S. L., Swain, S. L., Locksley, R. M., Haynes, L., Randall, T. D., & Cooper, A. M. (2007). IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nature Immunology, 8(4), 369–377.

Authors 14
  1. Shabaana A Khader (first)
  2. Guy K Bell (additional)
  3. John E Pearl (additional)
  4. Jeffrey J Fountain (additional)
  5. Javier Rangel-Moreno (additional)
  6. Garth E Cilley (additional)
  7. Fang Shen (additional)
  8. Sheri M Eaton (additional)
  9. Sarah L Gaffen (additional)
  10. Susan L Swain (additional)
  11. Richard M Locksley (additional)
  12. Laura Haynes (additional)
  13. Troy D Randall (additional)
  14. Andrea M Cooper (additional)
References 56 Referenced 1,159
  1. Corbett, E.L. et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163, 1009–1021 (2003). (10.1001/archinte.163.9.1009) / Arch. Intern. Med. by EL Corbett (2003)
  2. Nabeshima, S. et al. Kinetic analysis of Mycobacterium tuberculosis-specific cytokine production by PBMC in adults after BCG vaccination. J. Infect. Chemother. 11, 18–23 (2005). (10.1007/s10156-004-0357-8) / J. Infect. Chemother. by S Nabeshima (2005)
  3. Colditz, G.A. et al. Efficacy of BCG vaccine in the prevention of tuberculosis. J. Am. Med. Assoc. 271, 698–702 (1994). (10.1001/jama.1994.03510330076038) / J. Am. Med. Assoc. by GA Colditz (1994)
  4. Cooper, A.M., Callahan, J.E., Keen, M., Belisle, J.T. & Orme, I.M. Expression of memory immunity in the lung following re-exposure to Mycobacterium tuberculosis. Tuber. Lung Dis. 78, 67–73 (1997). (10.1016/S0962-8479(97)90017-4) / Tuber. Lung Dis. by AM Cooper (1997)
  5. Jung, Y.J., Ryan, L., Lacourse, R. & North, R. Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice. J. Exp. Med. 201, 1915–1924 (2005). (10.1084/jem.20050265) / J. Exp. Med. by YJ Jung (2005)
  6. Flynn, J.L. & Chan, J. Immunology of tuberculosis. Annu. Rev. Immunol. 19, 93–129 (2001). (10.1146/annurev.immunol.19.1.93) / Annu. Rev. Immunol. by JL Flynn (2001)
  7. Akahoshi, M. et al. Influence of interleukin-12 receptor β1 polymorphisms on tuberculosis. Hum. Genet. 112, 237–243 (2003). (10.1007/s00439-002-0873-5) / Hum. Genet. by M Akahoshi (2003)
  8. Tso, H.W., Lau, Y.L., Tam, C.M., Wong, H.S. & Chiang, A.K. Associations between IL12β polymorphisms and tuberculosis in the Hong Kong chinese population. J. Infect. Dis. 190, 913–919 (2004). (10.1086/422693) / J. Infect. Dis. by HW Tso (2004)
  9. Cooper, A.M., Magram, J., Ferrante, J. & Orme, I.M. IL-12 is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186, 39–46 (1997). (10.1084/jem.186.1.39) / J. Exp. Med. by AM Cooper (1997)
  10. Holscher, C. et al. A protective and agonistic function of IL-12p40 in mycobacterial infection. J. Immunol. 167, 6957–6966 (2001). (10.4049/jimmunol.167.12.6957) / J. Immunol. by C Holscher (2001)
  11. Cooper, A.M. et al. Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J. Immunol. 168, 1322–1327 (2002). (10.4049/jimmunol.168.3.1322) / J. Immunol. by AM Cooper (2002)
  12. Leal, I.S., Smedegard, B., Andersen, P. & Appelberg, R. Interleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine. Infect. Immun. 67, 5747–5754 (1999). (10.1128/IAI.67.11.5747-5754.1999) / Infect. Immun. by IS Leal (1999)
  13. Stobie, L. et al. The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge. Proc. Natl. Acad. Sci. USA 97, 8427–8432 (2000). (10.1073/pnas.160197797) / Proc. Natl. Acad. Sci. USA by L Stobie (2000)
  14. Khader, S.A. et al. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-γ responses if IL-12p70 is available. J. Immunol. 175, 788–795 (2005). (10.4049/jimmunol.175.2.788) / J. Immunol. by SA Khader (2005)
  15. Cruz, A. et al. CE:IFN-γ regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection1. J. Immunol. 177, 1416–1420 (2006). (10.4049/jimmunol.177.3.1416) / J. Immunol. by A Cruz (2006)
  16. Veldhoen, M., Hocking, R., Atkins, C., Locksley, R. & Stockinger, B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179–189 (2006). (10.1016/j.immuni.2006.01.001) / Immunity by M Veldhoen (2006)
  17. Mangan, P.R. et al. Transforming growth factor-β induces development of the TH17 lineage. Nature 441, 231–234 (2006). (10.1038/nature04754) / Nature by PR Mangan (2006)
  18. Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235–238 (2006). (10.1038/nature04753) / Nature by E Bettelli (2006)
  19. Aggarwal, S. & Gurney, A.L. IL-17: prototype member of an emerging cytokine family. J. Leukoc. Biol. 71, 1–8 (2002). (10.1189/jlb.71.1.1) / J. Leukoc. Biol. by S Aggarwal (2002)
  20. Langrish, C.L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233–240 (2005). (10.1084/jem.20041257) / J. Exp. Med. by CL Langrish (2005)
  21. Nakae, S., Nambu, A., Sudo, K. & Iwakura, Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171, 6173–6177 (2003). (10.4049/jimmunol.171.11.6173) / J. Immunol. by S Nakae (2003)
  22. Nakae, S. et al. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc. Natl. Acad. Sci. USA 100, 5986–5990 (2003). (10.1073/pnas.1035999100) / Proc. Natl. Acad. Sci. USA by S Nakae (2003)
  23. Fossiez, F. et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183, 2593–2603 (1996). (10.1084/jem.183.6.2593) / J. Exp. Med. by F Fossiez (1996)
  24. Jones, C.E. & Chan, K. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-α, and granulocyte-colony-stimulating factor by human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 26, 748–753 (2002). (10.1165/ajrcmb.26.6.4757) / Am. J. Respir. Cell Mol. Biol. by CE Jones (2002)
  25. Ye, P. et al. Requirement of Interleukin-17 receptor signalling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recriutment, and host defense. J. Exp. Med. 194, 519–527 (2001). (10.1084/jem.194.4.519) / J. Exp. Med. by P Ye (2001)
  26. Kolls, J.K., Kanaly, S.T. & Ramsay, A.J. Interleukin-17: An emerging role in lung inflammation. Am. J. Respir. Cell Mol. Biol. 28, 9–11 (2003). (10.1165/rcmb.2002-0255PS) / Am. J. Respir. Cell Mol. Biol. by JK Kolls (2003)
  27. Moseley, T.A., Haudenschild, D., Rose, L. & Reddi, A. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14, 155–174 (2003). (10.1016/S1359-6101(03)00002-9) / Cytokine Growth Factor Rev. by TA Moseley (2003)
  28. Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133–1141 (2005). (10.1038/ni1261) / Nat. Immunol. by H Park (2005)
  29. Harrington, L.E. et al. Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper 1 and 2 lineages. Nat. Immunol. 6, 1123–1132 (2005). (10.1038/ni1254) / Nat. Immunol. by LE Harrington (2005)
  30. Oppmann, B. et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13, 715–725 (2000). (10.1016/S1074-7613(00)00070-4) / Immunity by B Oppmann (2000)
  31. Parham, C. et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168, 5699–5708 (2002). (10.4049/jimmunol.168.11.5699) / J. Immunol. by C Parham (2002)
  32. Aggarwal, S., Ghilardi, N., Xie, M-H., deSauvage, F. & Gurney, A. Interleukin 23 promotes a distinct CD4 T cell activation state characterized by the production of IL-17. J. Biol. Chem. 278, 1910–1914 (2003). (10.1074/jbc.M207577200) / J. Biol. Chem. by S Aggarwal (2003)
  33. Winslow, G.M., Roberts, A.D., Blackman, M.A. & Woodland, D.L. Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse. J. Immunol. 170, 2046–2052 (2003). (10.4049/jimmunol.170.4.2046) / J. Immunol. by GM Winslow (2003)
  34. Evans, J. et al. Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529. Expert Rev. Vaccines 2, 219–229 (2003). (10.1586/14760584.2.2.219) / Expert Rev. Vaccines by J Evans (2003)
  35. Geisel, R.E., Sakamoto, K., Russell, D. & Rhoades, E. In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette-Guerin is due principally to trehalose mycolates. J. Immunol. 174, 5007–5015 (2005). (10.4049/jimmunol.174.8.5007) / J. Immunol. by RE Geisel (2005)
  36. Kim, C.H. & Broxmeyer, H.E. Chemokines: signal lamps for trafficking of T and B cells for development and effector function. J. Leukoc. Biol. 65, 6–15 (1999). (10.1002/jlb.65.1.6) / J. Leukoc. Biol. by CH Kim (1999)
  37. MacMicking, J.D., Taylor, G. & McKinney, J. Immune control of tuberculosis by IFN-γ-inducible LRG-47. Science 302, 654–659 (2003). (10.1126/science.1088063) / Science by JD MacMicking (2003)
  38. Shen, F., Hu, Z., Goswami, J. & Gaffen, S. Identification of common transcriptional regulatory elements in interleukin-17 target genes. J. Biol. Chem. 281, 24138–24148 (2006). (10.1074/jbc.M604597200) / J. Biol. Chem. by F Shen (2006)
  39. Reinhardt, R.L., Hong, S., Kang, S., Wang, Z. & Locksley, R. Visualization of IL-12/23p40 in vivo reveals immunostimulatory dendritic cell migrants that promote Th1 differentiation. J. Immunol. 177, 1618–1627 (2006). (10.4049/jimmunol.177.3.1618) / J. Immunol. by RL Reinhardt (2006)
  40. Wozniak, T.M., Ryan, A. & Britton, W. Interleukin-23 restores immunity to Mycobacterium tuberculosis infection in IL-12p40-deficient mice and is not required for the development of IL-17-secreting T cell responses. J. Immunol. 177, 8684–8692 (2006). (10.4049/jimmunol.177.12.8684) / J. Immunol. by TM Wozniak (2006)
  41. Veldhoen, M., Hocking, R., Flavell, R. & Stockinger, B. Signals mediated by transforming growth factor-β initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat. Immunol. 7, 1151–1156 (2006). (10.1038/ni1391) / Nat. Immunol. by M Veldhoen (2006)
  42. Belladonna, M.L. et al. IL-23 and IL-12 have overlapping, but distinct, effects on murine dendritic cells. J. Immunol. 168, 5448–5454 (2002). (10.4049/jimmunol.168.11.5448) / J. Immunol. by ML Belladonna (2002)
  43. Higgins, S.C., Jarnicki, A., Lavelle, E. & Mills, K. TLR4 Mediates vaccine-Induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J. Immunol. 177, 7980–7989 (2006). (10.4049/jimmunol.177.11.7980) / J. Immunol. by SC Higgins (2006)
  44. Baekkevold, E.S. et al. A role for CCR4 in development of mature circulating cutaneous T helper memory cell populations. J. Exp. Med. 201, 1045–1051 (2005). (10.1084/jem.20041059) / J. Exp. Med. by ES Baekkevold (2005)
  45. Byersdorfer, C.A. & Chaplin, D. Visualization of early APC/T cell interactions in the mouse lung following intranasal challenge. J. Immunol. 167, 6756–6764 (2001). (10.4049/jimmunol.167.12.6756) / J. Immunol. by CA Byersdorfer (2001)
  46. Kolls, J.K. & Linden, A. Interleukin-17 family members and inflammation. Immunity 21, 467–476 (2004). (10.1016/j.immuni.2004.08.018) / Immunity by JK Kolls (2004)
  47. Miyamoto, M. et al. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J. Immunol. 170, 4665–4672 (2003). (10.4049/jimmunol.170.9.4665) / J. Immunol. by M Miyamoto (2003)
  48. Appelberg, R. Neutrophils and intracellular pathogens: beyond phagocytosis and killing. Trends Microbiol. 15, 87–92 (2007). (10.1016/j.tim.2006.11.009) / Trends Microbiol. by R Appelberg (2007)
  49. Chackerian, A.A. et al. Neutralization or absence of the interleukin-23 pathway does not compromise immunity to mycobacterial infection. Infect. Immun. 74, 6092–6099 (2006). (10.1128/IAI.00621-06) / Infect. Immun. by AA Chackerian (2006)
  50. Gaffen, S.L. Biology of recently discovered cytokines: interleukin-17–a unique inflammatory cytokine with roles in bone biology and arthritis. Arthritis Res. Ther. 6, 240–247 (2004). (10.1186/ar1444) / Arthritis Res. Ther. by SL Gaffen (2004)
  51. Ghilardi, N. et al. Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice. J. Immunol. 172, 2827–2833 (2004). (10.4049/jimmunol.172.5.2827) / J. Immunol. by N Ghilardi (2004)
  52. Khader, S.A. et al. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J. Exp. Med. 203, 1805–1815 (2006). (10.1084/jem.20052545) / J. Exp. Med. by SA Khader (2006)
  53. Olsen, A.W., Hansen, P., Holm, A. & Andersen, P. Efficient protection against Mycobacterium tuberculosis by vaccination with a single immunodominant epitope from the ESAT-6 antigen. Eur. J. Immunol. 30, 1724–1732 (2000). (10.1002/1521-4141(200006)30:6<1724::AID-IMMU1724>3.0.CO;2-A) / Eur. J. Immunol. by AW Olsen (2000)
  54. Happel, K.I. et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202, 761–769 (2005). (10.1084/jem.20050193) / J. Exp. Med. by KI Happel (2005)
  55. Hollenbaugh, J.A. & Dutton, R. IFN-γ regulates donor CD8 T cell expansion, migration and leads to solid tumor apoptosis. J. Immunol. 177, 3004–3011 (2006). (10.4049/jimmunol.177.5.3004) / J. Immunol. by JA Hollenbaugh (2006)
  56. Flano, E., Kayhan, B., Woodland, D. & Blackman, M. Infection of dendritic cells by a γ2-herpesvirus induces functional modulation. J. Immunol. 175, 3225–3234 (2005). (10.4049/jimmunol.175.5.3225) / J. Immunol. by E Flano (2005)
Dates
Type When
Created 18 years, 5 months ago (March 11, 2007, 11:58 a.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 6:47 p.m.)
Indexed 3 days, 8 hours ago (Sept. 3, 2025, 6:15 a.m.)
Issued 18 years, 5 months ago (March 11, 2007)
Published 18 years, 5 months ago (March 11, 2007)
Published Online 18 years, 5 months ago (March 11, 2007)
Published Print 18 years, 5 months ago (April 1, 2007)
Funders 0

None

@article{Khader_2007, title={IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge}, volume={8}, ISSN={1529-2916}, url={http://dx.doi.org/10.1038/ni1449}, DOI={10.1038/ni1449}, number={4}, journal={Nature Immunology}, publisher={Springer Science and Business Media LLC}, author={Khader, Shabaana A and Bell, Guy K and Pearl, John E and Fountain, Jeffrey J and Rangel-Moreno, Javier and Cilley, Garth E and Shen, Fang and Eaton, Sheri M and Gaffen, Sarah L and Swain, Susan L and Locksley, Richard M and Haynes, Laura and Randall, Troy D and Cooper, Andrea M}, year={2007}, month=mar, pages={369–377} }